ArticleTherapeutic advances in medical oncology2026
Efficacy and safety of induction chemoimmunotherapy in older patients with unresectable stage III NSCLC: a real-world multicenter study.
Xingyu Du et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.